Skip to content
akaturk Academic measurement
Sign in Register

Academician

ŞAFAK YALÇIN ŞAHİNER

DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)

ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Ruh Sağlığı ve Hastalıkları

A quick look at recorded outputs — details below.

  • Articles 34
  • Projects 0
  • Books 0
  • Proceedings 24
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 9 Q2 4 Q3 14 Q4 6
WoS (JCR) Q1 6 Q2 5 Q3 3 Q4 18
TR Index 11 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 0
Avg percentile 45.5%
Top 1% share 0.0%
Top 10% share 0.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

34 publications total

Scopus (SJR)
Q1 9 Q2 4 Q3 14 Q4 6
WoS (JCR)
Q1 6 Q2 5 Q3 3 Q4 18
TR Index
11 articles

Article list

  1. 2026 An investigation of university students perspectives on combating addiction: a qualitative study Frontiers in Public Health DOI 10.3389/fpubh.2026.1860766 YÖKSİS SJR Q1 JCR Q1 OpenAlex 63.5%
  2. 2025 Hashimoto’s encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment Frontiers in Psychiatry DOI 10.3389/fpsyt.2025.1639179 YÖKSİS SJR Q1 JCR Q2 OpenAlex 72.5%
  3. 2025 Türkiye’de Yeni Nesil Psikoaktif Maddeler Gerçeği: 2013’ten Günümüze Yaşanan Değişimler: Sistematik Derleme Türkiye Klinikleri Adli Tıp ve Adli Bilimler Dergisi DOI 10.5336/forensic.2024-104914 YÖKSİS TR Index OpenAlex 39.8%
  4. 2025 Evaluation of thiol/disulfide homeostasis and ischemia-modified albumin levels in patients diagnosed with heroin use disorder. 10.62401/2531-4122-2025-12 DOI 10.62401/2531-4122-2025-12 YÖKSİS SJR Q4 JCR Q4 OpenAlex 19.3%
  5. 2024 Opioid Kullanım Bozukluğu Olan Bireyler ile Obezitesi Olan Bireylerin Bağlanma Biçimlerinin Karşılaştırılması Türk Psikiyatri Dergisi DOI 10.5080/u27003 YÖKSİS TR Index SJR Q3 OpenAlex 17.0%
  6. 2024 Comparison of the immunoassay method with the commercial and in-house LC-MS/ MS methods for substance abuse in urine Turkish Journal of Biochemistry DOI 10.1515/tjb-2022-0286 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 44.7%
  7. 2024 Affective neuroscience personality traits in opioid use disorder patients: The relationship with earlier onset of substance use, the severity of addiction, and motivational factors to quit opiate use Brain and Behavior DOI 10.1002/brb3.70050 YÖKSİS SJR Q2 JCR Q2 OpenAlex 20.5%
  8. 2023 Association of OPRK1 rs963549 and rs997917 Polymorphisms With Opioid Use Disorder and Related Phenotypes Pharmacogenomics DOI 10.2217/pgs-2023-0037 YÖKSİS SJR Q3 JCR Q3 OpenAlex 59.9%
  9. 2022 Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder Environmental Toxicology and Pharmacology DOI 10.1016/j.etap.2022.103979 YÖKSİS SJR Q1 JCR Q1 OpenAlex 75.8%
  10. 2022 Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use European Journal of Pharmacology DOI 10.1016/j.ejphar.2022.174862 YÖKSİS SJR Q1 JCR Q1 OpenAlex 36.7%
  11. 2022 Effects of UGT2B7 rs7662029 and rs7439366 polymorphisms on sublingual buprenorphine metabolism in heroin addicts: An improved PCR-RFLP assay for the detection of rs7662029 polymorphism Environmental Toxicology and Pharmacology DOI 10.1016/j.etap.2022.103902 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.2%
  12. 2022 Opioid Kullanım Bozukluğu Olan Hastalarda Psikolojik Dayanıklılığın Tedavi Devamlılığı İle İlişkisi Bağımlılık Dergisi DOI 10.51982/bagimli.1004190 YÖKSİS TR Index OpenAlex 64.8%
  13. 2021 Association of Glial Cell-Line Derived Neurotrophic Factor and Nerve Growth Factor with Duration of Untreated Psychosis and Clinical Symptoms in Drug-Naive Schizophrenia Psychiatry and Clinical Psychopharmacology DOI 10.5152/pcp.2021.21715 YÖKSİS SJR Q3 JCR Q4 OpenAlex 35.9%
  14. 2021 Effect of PDYN rs2281285, rs2235749 and rs910080 gene polymorphisms on the intensity of depression symptoms and negative craving in heroin addicts Archives of Biological Sciences DOI 10.2298/ABS210929041K YÖKSİS SJR Q3 JCR Q4 OpenAlex 49.6%
  15. 2021 Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls Clinical Biochemistry DOI 10.1016/j.clinbiochem.2021.04.009 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.7%
  16. 2021 Akut İskemik İnme ve Geçici İskemik Atak Geçiren Hastalarda Mizaç Kişilik Özellikleri ve Yaşam Olaylarının İncelenmesi Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi DOI 10.20492/aeahtd.877071 YÖKSİS TR Index OpenAlex 12.8%
  17. 2019 Pregabalin abuse among patients with opioid use disorders may increase the severity of withdrawal symptoms: a single-center, case-control study Psychiatry and Clinical Psychopharmacology DOI 10.1080/24750573.2019.1673946 YÖKSİS SJR Q3 JCR Q4 OpenAlex 80.4%
  18. 2019 Comparison of sociodemographic features, psychopathy and aggression levels of criminal and non-criminal schizophrenia patients Anadolu Psikiyatri Dergisi-Anatolian Journal of Psychiatry DOI 10.5455/apd.6538 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 67.7%
  19. 2018 Majör depresif bozukluk tanısı ile başvuran hastalarda beden kitle indeksinin depresyon şiddeti, yeme tutumu ve dürtüsellikle ilişkisi Anadolu Psikiyatri Dergisi-Anatolian Journal of Psychiatry DOI 10.5455/apd.266257 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 15.8%
  20. 2017 Identification of a Novel Metabolite Originating from AM-630, a Potent and Selective Inverse Agonist for the Cannabinoid Receptor CB2 (9th ICP) Psychiatry and Clinical Psychopharmacology DOI 10.1080/24750573.2017.1308707 YÖKSİS SJR Q3 JCR Q4 OpenAlex 23.4%

Back to academicians